Metraipolis › archive › dc_d22d10aa7570

Integrated molecular and ADME-toxicity profiling identifies PGV-5 and HGV-5 as potential agents to counteract multidrug-resistant (MDR) cancer — Europe PMC PMID:41120301

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41120301
DOI
10.1038/s41598-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-11-09T04:46:25.239Z
SHA-256 of the archived text
4956eca783be68ee5785742270ca5f1287b832c2ec76c456da6368e472bf0de7
Stable URL of this page
https://metraipolis.com/documento/dc_d22d10aa7570

How to cite

Integrated molecular and ADME-toxicity profiling identifies PGV-5 and HGV-5 as potential agents to counteract multidrug-resistant (MDR) cancer — Europe PMC PMID:41120301 — Europe PMC (en), https://europepmc.org/article/MED/41120301 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d22d10aa7570 (Metraipolis archive dc_d22d10aa7570, sha256 4956eca783be68ee5785742270ca5f1287b832c2ec76c456da6368e472bf0de7)
BibTeX
@misc{dcd22d10aa7570,
  title = {Integrated molecular and ADME-toxicity profiling identifies PGV-5 and HGV-5 as potential agents to counteract multidrug-resistant (MDR) cancer — Europe PMC PMID:41120301},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41120301},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d22d10aa7570; sha256 4956eca783be68ee5785742270ca5f1287b832c2ec76c456da6368e472bf0de7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41120301. Agents can read the archived copy with the MCP tool read_document.